NetworkNewsBreaks – Avricore Health Inc. (TSX.V:
Post# of 61
(Total Views: 196)
Posted On: 12/29/2021 3:20:16 PM
NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Taking Part in POC Testing Revolution with HealthTab(TM)
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is positioning in an era where point-of-care (“POC”) testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more. In the shift to a more decentralized testing approach, Avricore is taking part in this disruption through its POCT platform, HealthTab(TM), found at select community pharmacies. “HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results,” reads a recent article. “The analyzers screen for more than 20 biomarkers associated with select chronic and infectious diseases and communicate them in real-time with patients and trained health care professionals. In a November 23 announcement, Avricore celebrated the signing of a distribution agreement with Abbott that expanded its platform’s capabilities to better support patients with vital information about their renal function.” Avricore CEO Hector Bremner was quoted on the move as saying, “Understanding renal function in patients at risk from or already living with chronic disease is critical. With i-STAT Alinity and its associated test for creatinine, health care professionals can obtain results in approximately two minutes to detect elevated levels of creatinine that are associated with abnormal renal function.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is positioning in an era where point-of-care (“POC”) testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more. In the shift to a more decentralized testing approach, Avricore is taking part in this disruption through its POCT platform, HealthTab(TM), found at select community pharmacies. “HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results,” reads a recent article. “The analyzers screen for more than 20 biomarkers associated with select chronic and infectious diseases and communicate them in real-time with patients and trained health care professionals. In a November 23 announcement, Avricore celebrated the signing of a distribution agreement with Abbott that expanded its platform’s capabilities to better support patients with vital information about their renal function.” Avricore CEO Hector Bremner was quoted on the move as saying, “Understanding renal function in patients at risk from or already living with chronic disease is critical. With i-STAT Alinity and its associated test for creatinine, health care professionals can obtain results in approximately two minutes to detect elevated levels of creatinine that are associated with abnormal renal function.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Avricore Health Inc. (AVCRF) Stock Research Links
Scroll down for more posts ▼